Literature DB >> 9794369

Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo.

T De Smedt1, B Pajak, G G Klaus, R J Noelle, J Urbain, O Leo, M Moser.   

Abstract

The potent accessory properties of dendritic cells (DC) develop sequentially during a process termed "maturation." Splenic DC undergo functional maturation in vivo in response to the bacterial product LPS and migrate from the marginal zone to the T cell areas. The redistribution of fully mature DC, which present Ags encountered in the periphery, in the T cell area is likely to result in T cell priming. Unexpectedly, we found that DC rapidly die by apoptosis once they have entered the T cell zone. Injection of OVA peptide in OVA-specific, TCR-transgenic mice strongly delays the LPS-induced apoptosis of DC in situ. We conclude that mature DC are programmed to die unless they receive a survival signal from T cells and that the regulation of DC survival may be a mechanism aimed at controlling the initiation and the termination of the immune response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794369

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

2.  Immunohistowax processing, a new fixation and embedding method for light microscopy, which preserves antigen immunoreactivity and morphological structures: visualisation of dendritic cells in peripheral organs.

Authors:  B Pajak; T De Smedt; V Moulin; C De Trez; R Maldonado-López; G Vansanten; E Briend; J Urbain; O Leo; M Moser
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

Review 3.  The regulation and activation potential of autoreactive B cells.

Authors:  Michele L Fields; Su-Jean Seo; Simone A Nish; Jeff H Tsai; Andrew J Caton; Jan Erikson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Toward a better analysis of secreted proteins: the example of the myeloid cells secretome.

Authors:  Mireille Chevallet; Hélène Diemer; Alain Van Dorssealer; Christian Villiers; Thierry Rabilloud
Journal:  Proteomics       Date:  2007-06       Impact factor: 3.984

Review 5.  Tissue-based class control: the other side of tolerance.

Authors:  Polly Matzinger; Tirumalai Kamala
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

6.  Natural killer T cells are essential for the development of contact hypersensitivity in BALB/c mice.

Authors:  Chihiro Shimizuhira; Atsushi Otsuka; Tetsuya Honda; Akihiko Kitoh; Gyohei Egawa; Saeko Nakajima; Chisa Nakashima; Hiroshi Watarai; Yoshiki Miyachi; Kenji Kabashima
Journal:  J Invest Dermatol       Date:  2014-04-22       Impact factor: 8.551

7.  EF24 suppresses maturation and inflammatory response in dendritic cells.

Authors:  Prachi Vilekar; Shanjana Awasthi; Aravindan Natarajan; Shrikant Anant; Vibhudutta Awasthi
Journal:  Int Immunol       Date:  2012-02-29       Impact factor: 4.823

8.  4-1BB functions as a survival factor in dendritic cells.

Authors:  Beom K Choi; Young H Kim; Patrick M Kwon; Sang C Lee; Sang W Kang; Moon S Kim; Myoung J Lee; Byoung S Kwon
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

9.  Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity.

Authors:  Brian M Janelsins; Alicia R Mathers; Olga A Tkacheva; Geza Erdos; William J Shufesky; Adrian E Morelli; Adriana T Larregina
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

10.  CD40/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory molecules.

Authors:  Ivana R Ferrer; Danya Liu; David F Pinelli; Brent H Koehn; Linda L Stempora; Mandy L Ford
Journal:  J Immunol       Date:  2012-09-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.